CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

415 hedge funds and large institutions have $3.07B invested in CRISPR Therapeutics in 2023 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 94 increasing their positions, 136 reducing their positions, and 26 closing their positions.

Holders
415
Holders Change
+36
Holders Change %
+9.5%
% of All Funds
6.55%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
65
Increased
94
Reduced
136
Closed
26
Calls
$142M
Puts
$112M
Net Calls
+$30M
Net Calls Change
+$22.1M

Top Buyers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$25.7M
2
FCM
2
Frontier Capital Management
Massachusetts
$21.1M
3
Bank of America
3
Bank of America
North Carolina
$42.4M
4
CIM
4
Contrarius Investment Management
Jersey
$12.9M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$24.3M

Top Sellers

1
AIM
1
ARK Investment Management
Florida
$412M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$198M
3
NAMA
3
Nikko Asset Management Americas
New York
$198M
4
State Street
4
State Street
Massachusetts
$91.6M
5
AC
5
Armistice Capital
New York
$28.1M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$412M 7,338,447 -651,741 -8%
Capital International Investors
2
Capital International Investors
California
$341M 6,069,723 +46,085 +0.8%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$205M 3,646,582 -17,789 -0.5%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$198M 3,533,357 -439,823 -11%
NAMA
5
Nikko Asset Management Americas
New York
$198M 3,533,357 -438,782 -11%
BlackRock
6
BlackRock
New York
$153M 2,718,575 -80,006 -3%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$117M 2,091,173 -47,883 -2%
State Street
8
State Street
Massachusetts
$91.6M 1,632,473 -353,714 -18%
NMC
9
NEA Management Company
Maryland
$89.1M 1,587,854 – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$86M 1,531,090 +46,521 +3%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$64.4M 1,147,929 -8,881 -0.8%
CS
12
Credit Suisse
Switzerland
$51.7M 921,656 +74,383 +9%
BG
13
Bellevue Group
Switzerland
$50.5M 899,300 -500 -0.1%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$49.5M 882,375 -220,346 -20%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$46.9M 834,607 +24,623 +3%
Bank of America
16
Bank of America
North Carolina
$42.4M 754,557 +236,851 +46%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$39.9M 711,271 -48,464 -6%
Charles Schwab
18
Charles Schwab
California
$36.3M 646,711 +5,934 +0.9%
Norges Bank
19
Norges Bank
Norway
$32.4M 577,033 -52,619 -8%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$31M 551,395 -31,269 -5%
Federated Hermes
21
Federated Hermes
Pennsylvania
$28.6M 508,758 – –
AC
22
Armistice Capital
New York
$28.1M 500,000 -324,000 -39%
VVM
23
Versant Venture Management
California
$28M 498,558 – –
Marshall Wace
24
Marshall Wace
United Kingdom
$25.7M 457,008 +457,008 New
Two Sigma Investments
25
Two Sigma Investments
New York
$24.3M 433,071 +217,037 +100%
1
2 3 4 5